OTCMKTS:PROTStromacel Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Stromacel Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $0.02 0.00 (0.00 %) (As of 08/3/2020 04:00 PM ET) Add Compare Share Today's Range$0.02Now: $0.02▼$0.0250-Day Range$0.01MA: $0.02▼$0.0352-Week Range$0.00Now: $0.02▼$0.05Volume500 shsAverage Volume10,357 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABetaN/A ProfileAdvanced ChartCompetitorsFinancialsHeadlinesSEC FilingsSocial Media Proteonomix, Inc., a biotechnology company, focuses on developing therapeutics based upon the use of human cells and their derivatives. The company's products include Proteoderm, an anti-aging skin cream based on a proprietary and patented matrix of proteins that reduce wrinkles; UMK-121, a treatment for liver disease using a combination of two or three approved drugs to mobilize particular bone marrow stem cells; and StromaCel, a treatment for cardiac patients within two weeks of a myocardial infarction using stem cells derived from donor bone marrow and administered through IV solution to repair heart tissue. Its products also comprise NC-138, a proprietary matrix of proteins, which act on the skin to enhance activities that reduce wrinkles. The company was formerly known as National Stem Cell Holding, Inc. and changed its name to Proteonomix, Inc. in August 2008. Proteonomix, Inc. was incorporated in 1995 and is based in Hawthorne, New Jersey.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for Stromacel. Previous Next 2.4 Community Rank Outperform VotesStromacel has received 35 “outperform” votes. (Add your “outperform” vote.)Underperform VotesStromacel has received 39 “underperform” votes. (Add your “underperform” vote.)Community SentimentStromacel has received 52.70% “underperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Stromacel and other stocks. Vote “Outperform” if you believe PROT will outperform the S&P 500 over the long term. Vote “Underperform” if you believe PROT will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldStromacel does not currently pay a dividend.Dividend GrowthStromacel does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Stromacel insiders have not sold or bought any company stock. Previous Next 0.0 Earnings and Valuation Previous Next Analyst Opinion: 0.0Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.48 out of 5 stars Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Biotechnology Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:PROT Previous Symbol CUSIPN/A CIK1000897 Webstromacel.com Phone+1-973-5446116Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding SharesN/AMarket CapN/A Next Earnings DateN/A OptionableNot Optionable $0.02 0.00 (0.00 %) (As of 08/3/2020 04:00 PM ET) 30 days | 90 days | 365 days | Advanced Chart Receive PROT News and Ratings via Email Sign-up to receive the latest news and ratings for PROT and its competitors with MarketBeat's FREE daily newsletter. Stromacel (OTCMKTS:PROT) Frequently Asked Questions How has Stromacel's stock been impacted by COVID-19 (Coronavirus)? Stromacel's stock was trading at $0.01 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, PROT shares have increased by 100.0% and is now trading at $0.02. View which stocks have been most impacted by Coronavirus. Has Stromacel been receiving favorable news coverage? News coverage about PROT stock has trended negative recently, according to InfoTrie. InfoTrie identifies positive and negative news coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Stromacel earned a daily sentiment score of -2.9 on InfoTrie's scale. They also gave media headlines about the biotechnology company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an effect on the stock's share price in the next several days. View the latest news about Stromacel. Who are some of Stromacel's key competitors? Some companies that are related to Stromacel include Abattis Bioceuticals (ATTBF), ABcann Global (ABCN), ABZENA/PAR VTG FPD 0.002 (ABZA), Admedus (AHZ), Almirall (LBTSF), Amarantus Bioscience (AMBS), Antibe Therapeutics (VBIZF), Aortech International (RUA), Apotheca Biosciences (CBDC), Arno Therapeutics (ARNI), Axim Biotechnologies (AXIM), Baudax Bio (BXRXV), BerGenBio ASA (BRRGF), Biocure Technology (CURE) and Canada House Wellness Group (CHV). View all competitors. Who are Stromacel's key executives? Stromacel's management team includes the following people: Mr. Michael Cohen, Founder, Chairman, CEO, Pres & COO (Age 52)Mr. Steven Byle, CTO & Director (Age 51)Mr. Jason B. Isaacs, Sec. (Age 47)Ms. Jaci Mandil, Chief Exec. Officer of Proteoderm What is Stromacel's stock symbol? Stromacel trades on the OTCMKTS under the ticker symbol "PROT." How do I buy shares of Stromacel? Shares of PROT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is Stromacel's stock price today? One share of PROT stock can currently be purchased for approximately $0.02. What is Stromacel's official website? The official website for Stromacel is stromacel.com. How can I contact Stromacel? Stromacel's mailing address is 187 Mill Ln, MOUNTAINSIDE, NJ 07092-2918, United States. The biotechnology company can be reached via phone at +1-973-5446116. This page was last updated on 8/3/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
